Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
B.A.D. Etf stock logo
BAD
B.A.D. Etf
$11.91
$11.91
$11.11
$13.72
$9.77M0.961,591 shsN/A
GBF
iShares Government/Credit Bond ETF
$102.23
+0.3%
$102.39
$96.03
$106.19
$219.79M0.1225,766 shs2,681 shs
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
$0.37
-2.6%
$0.38
$0.19
$2.65
$6.48M3.081.39 million shs210,850 shs
Stantec Inc. stock logo
STN
Stantec
$84.76
-0.7%
$82.65
$56.49
$87.53
$9.67B1.05110,735 shs35,833 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
B.A.D. Etf stock logo
BAD
B.A.D. Etf
0.00%0.00%0.00%0.00%-9.92%
GBF
iShares Government/Credit Bond ETF
+0.14%+0.65%-0.37%-2.02%-3.55%
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
-38.96%-37.55%-48.34%-40.84%-45.82%
Stantec Inc. stock logo
STN
Stantec
+1.93%+5.00%+3.40%+5.79%+40.10%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/AN/AN/AN/AN/AN/A
GBF
iShares Government/Credit Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
Stantec Inc. stock logo
STN
Stantec
3.1623 of 5 stars
2.32.03.30.02.41.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
B.A.D. Etf stock logo
BAD
B.A.D. Etf
0.00
N/A$15.2728.18% Upside
GBF
iShares Government/Credit Bond ETF
0.00
N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
2.00
HoldN/AN/A
Stantec Inc. stock logo
STN
Stantec
2.50
Moderate Buy$105.0023.88% Upside

Current Analyst Ratings

Latest STN, BAD, HILS, GBF, and MGNS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/29/2024
Stantec Inc. stock logo
STN
Stantec
Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Sector Perform
(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/AN/AN/AN/A
GBF
iShares Government/Credit Bond ETF
N/AN/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/A$0.48 per shareN/A
Stantec Inc. stock logo
STN
Stantec
$4.80B2.01$4.55 per share18.63$17.90 per share4.74

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/A14.31N/AN/AN/AN/AN/A
GBF
iShares Government/Credit Bond ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
-$8.47M-$0.72N/AN/AN/AN/A-188.44%-149.61%N/A
Stantec Inc. stock logo
STN
Stantec
$245.35M$2.2038.5323.29N/A5.11%16.50%6.86%5/8/2024 (Confirmed)

Latest STN, BAD, HILS, GBF, and MGNS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Stantec Inc. stock logo
STN
Stantec
$0.67N/A-$0.67N/AN/AN/A  
2/28/2024Q4 2023
Stantec Inc. stock logo
STN
Stantec
$0.63$0.60-$0.03$0.72$891.12 million$912.51 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
B.A.D. Etf stock logo
BAD
B.A.D. Etf
$0.080.67%N/AN/AN/A
GBF
iShares Government/Credit Bond ETF
$2.182.13%N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/A
Stantec Inc. stock logo
STN
Stantec
$0.580.68%+7.95%26.36%12 Years

Latest STN, BAD, HILS, GBF, and MGNS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/1/2024
Stantec Inc. stock logo
STN
Stantec
quarterly$0.15480.8%3/27/20243/28/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/A
GBF
iShares Government/Credit Bond ETF
N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/A
3.01
3.01
Stantec Inc. stock logo
STN
Stantec
0.36
1.41
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/A
GBF
iShares Government/Credit Bond ETF
N/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
13.36%
Stantec Inc. stock logo
STN
Stantec
63.86%

Insider Ownership

CompanyInsider Ownership
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/A
GBF
iShares Government/Credit Bond ETF
N/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
30.24%
Stantec Inc. stock logo
STN
Stantec
0.46%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/A820,000N/ANot Optionable
GBF
iShares Government/Credit Bond ETF
N/A2.15 millionN/ANot Optionable
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
117.60 million12.28 millionNot Optionable
Stantec Inc. stock logo
STN
Stantec
28,000114.07 million113.54 millionOptionable

STN, BAD, HILS, GBF, and MGNS Headlines

SourceHeadline
Brokers Issue Forecasts for Stantec Inc.s Q1 2024 Earnings (NYSE:STN)Brokers Issue Forecasts for Stantec Inc.'s Q1 2024 Earnings (NYSE:STN)
americanbankingnews.com - May 6 at 1:22 AM
National Bank of Canada FI Reduces Holdings in Stantec Inc. (NYSE:STN)National Bank of Canada FI Reduces Holdings in Stantec Inc. (NYSE:STN)
marketbeat.com - May 5 at 9:02 PM
Two groups have mixed-use redevelopment visions for MOSIs Tampa propertyTwo groups have mixed-use redevelopment visions for MOSI's Tampa property
bizjournals.com - May 1 at 5:19 PM
Stantec acquires U.K. engineering form Hydrock, terms not disclosedStantec acquires U.K. engineering form Hydrock, terms not disclosed
msn.com - May 1 at 12:19 PM
Stantec acquires U.K. engineering firm Hydrock, terms not disclosedStantec acquires U.K. engineering firm Hydrock, terms not disclosed
theglobeandmail.com - May 1 at 12:19 PM
Stantec (STN) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseStantec (STN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
zacks.com - May 1 at 11:06 AM
Stantec acquires Hydrock, a UK integrated engineering design firmStantec acquires Hydrock, a UK integrated engineering design firm
globenewswire.com - May 1 at 6:45 AM
Stantec (STN) Scheduled to Post Quarterly Earnings on WednesdayStantec (STN) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - May 1 at 4:58 AM
Millions at stake in trial over value of downtown Albany landMillions at stake in trial over value of downtown Albany land
bizjournals.com - April 30 at 9:18 PM
Duff & Phelps Investment Management Co. Sells 50,348 Shares of Stantec Inc. (NYSE:STN)Duff & Phelps Investment Management Co. Sells 50,348 Shares of Stantec Inc. (NYSE:STN)
marketbeat.com - April 30 at 12:52 PM
Stantec selected by BC Hydro to provide Transmission & Distribution Engineering and Project Delivery ServicesStantec selected by BC Hydro to provide Transmission & Distribution Engineering and Project Delivery Services
globenewswire.com - April 30 at 6:45 AM
Jennison Associates LLC Invests $4.06 Million in Stantec Inc. (NYSE:STN)Jennison Associates LLC Invests $4.06 Million in Stantec Inc. (NYSE:STN)
marketbeat.com - April 27 at 6:08 AM
Q1 2024 Earnings Forecast for Stantec Inc. Issued By Desjardins (NYSE:STN)Q1 2024 Earnings Forecast for Stantec Inc. Issued By Desjardins (NYSE:STN)
marketbeat.com - April 24 at 5:58 AM
Reading City Council hears proposal for location of train stationReading City Council hears proposal for location of train station
wfmz.com - April 23 at 1:45 AM
46-story tower proposed near Fort Lauderdale Brightline (Photos)46-story tower proposed near Fort Lauderdale Brightline (Photos)
bizjournals.com - April 22 at 3:33 PM
San Diego may scale back its ambitious Pure Water sewage-purification plans — or scrap some entirelySan Diego may scale back its ambitious Pure Water sewage-purification plans — or scrap some entirely
sandiegouniontribune.com - April 22 at 9:22 AM
Stantec announces dates for first quarter 2024 results and conference call and annual general meeting of shareholdersStantec announces dates for first quarter 2024 results and conference call and annual general meeting of shareholders
globenewswire.com - April 17 at 5:00 PM
Zurcher Kantonalbank Zurich Cantonalbank Has $31.06 Million Holdings in Stantec Inc. (NYSE:STN)Zurcher Kantonalbank Zurich Cantonalbank Has $31.06 Million Holdings in Stantec Inc. (NYSE:STN)
marketbeat.com - April 17 at 9:41 AM
Growth in downtown Reading needs to be supported by policy, officials sayGrowth in downtown Reading needs to be supported by policy, officials say
wfmz.com - April 16 at 5:09 PM
Stantec Inc. (NYSE:STN) Position Cut by Mackenzie Financial CorpStantec Inc. (NYSE:STN) Position Cut by Mackenzie Financial Corp
marketbeat.com - April 15 at 1:53 PM
Ceredex Value Advisors LLC Sells 86,800 Shares of Stantec Inc. (NYSE:STN)Ceredex Value Advisors LLC Sells 86,800 Shares of Stantec Inc. (NYSE:STN)
marketbeat.com - April 8 at 8:27 AM
Stantec Inc. (NYSE:STN) Position Cut by DekaBank Deutsche GirozentraleStantec Inc. (NYSE:STN) Position Cut by DekaBank Deutsche Girozentrale
marketbeat.com - April 7 at 12:18 PM
Investors Will Want Stantecs (TSE:STN) Growth In ROCE To PersistInvestors Will Want Stantec's (TSE:STN) Growth In ROCE To Persist
finance.yahoo.com - April 4 at 9:44 AM
Stantec reports $3.9 billion of 2023 revenue aligned with Sustainable Development Goals in 17th annual Sustainability ReportStantec reports $3.9 billion of 2023 revenue aligned with Sustainable Development Goals in 17th annual Sustainability Report
globenewswire.com - April 2 at 6:45 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

B.A.D. Etf logo

B.A.D. Etf

NYSEARCA:BAD
The B.A.D. ETF (BAD) is an exchange-traded fund that is based on the EQM BAD index. The fund tracks a modified equal-weighted index of US-listed companies engaged in betting, alcohol, cannabis, and drugs. BAD was launched on Dec 22, 2021 and is managed by The BAD Investment Company.

iShares Government/Credit Bond ETF

NYSEARCA:GBF
iShares Government/Credit Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of the United States dollar-denominated government, government-related and investment-grade the United States corporate bonds. The Fund seeks to track the investment results of the Barclays U.S. Government/Credit Bond Index (the Underlying Index), which measures the performance of the United States dollar-denominated United States Treasury bonds, government-related bonds (i.e., the United States and foreign agencies, sovereign, supranational and local authority debt) and investment-grade United States corporate bonds, which have a remaining maturity of greater than or equal to one year. The Underlying Index may include large-, mid- or small-capitalization companies, and components include agency and treasury securities, and financial and industrials companies. BlackRock Fund Advisors serves as investment adviser of the Fund.
Hillstream BioPharma logo

Hillstream BioPharma

NASDAQ:HILS
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
Stantec logo

Stantec

NYSE:STN
Stantec Inc. provides professional services in the areas of infrastructure and facilities to the public and private sectors in Canada, the United States, and internationally. It offers evaluation, planning, and designing infrastructure solutions; solutions for sustainable water resources, planning, management, and infrastructure; environmental services; integrated architecture, engineering, interior design, and planning solutions for buildings; and energy and resources solutions. The company also provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. In addition, it offers planning and design services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. Further, the company provides transportation advisory, transport engineering, and technical design; project delivery consultancy services for mining, resources, and industrial infrastructure projects; paleontological and archaeological services for the rail, transportation, water, and power and energy sectors; and environmental and cultural resource compliance services. Additionally, it offers consulting services in sustainable building design, energy infrastructure upgrades, sustainable district heating network, and e-mobility; and planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.